Produktbild
Stuart Walker

Benefit-Risk Appraisal of Medicines

A systematic approach to decision-making

Ebook (PDF Format)

Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company. Despite this there are very few tried and tested evaluative models currently available. The authors of this book have developed a new, pioneering tool for the assessment of benefits and risks for new medicines in development and their regulatory reviews. This model utilises a multi-criteria decision analysis which involves selecting, scoring and weighting key… Mehr

CHF 92.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails


Weitere Autoren: Mussen, Filip / Salek, Sam
  • ISBN: 978-0-470-74812-1
  • EAN: 9780470748121
  • Produktnummer: 13841914
  • Verlag: Wiley
  • Sprache: Englisch
  • Erscheinungsjahr: 2009
  • Seitenangabe: 304 S.
  • Plattform: PDF
  • Masse: 2'710 KB

Über den Autor


Dr Sam Salek, Reader in Pharmacoepidemiology, Director - WSP Centre for Socioeconomic Research; Director - Postgraduate Course in Pharmaceutical Medicine, Cardiff University, UK. Mr Filip Mussen, Johnson & Johnson Pharmaceuticals Research and Development, Belgium. Prof Stuart Walker, President and Founder, International Institute for Regulatory Science, UK.

90 weitere Werke von Stuart Walker:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.